Cognitive Behaviour Therapy (CBT) for Body Dysmorphic Disorder (BDD)

Status Completed

Clinical Trial Summary

The aim of the research is to determine if Cognitive Behaviour Therapy (CBT) specific for BDD is more effective than a credible non-specific form of CBT for treating BDD and its delusional variant in adults aged 17 or over. This will be done in a single centre randomised controlled trial that compares specific CBT for BDD versus non-specific CBT over 12 weeks. The hypotheses to be tested are that: (1) specific CBT for BDD will be more effective than non-specific CBT at 12 weeks (2) Treatment effects from Specific CBT will be maintained at 1 month follow up. The main study end-point is at 12 weeks and the secondary end-point is at 1 month follow up. A secondary aim is to explore whether delusionality (insight) as measured by the Brown Assessment of Beliefs and co-morbid depressed mood predicts response to treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00871143
Study type	Interventional
Source	Institute of Psychiatry, London
Contact
Status	Completed
Phase	N/A
Start date	April 2009
Completion date	September 2012

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02635152` - Interpretation Bias Modification for Body Dysmorphic Disorder	N/A
Completed	`NCT03673046` - Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)	N/A
Recruiting	`NCT05402475` - Online Cognitive Behavioural Therapy Intervention for Body Dysmorphic Disorder	N/A
Withdrawn	`NCT02843451` - Milk Thistle in Body Dysmorphic Disorder	Phase 2
Completed	`NCT02010619` - Internet Delivered CBT for Body Dysmorphic Disorder	N/A
Completed	`NCT00842309` - D-Cycloserine Augmentation of Behavior Therapy for Individuals With Body Dysmorphic Disorder	Early Phase 1
Completed	`NCT00245635` - Fluoxetine in Pediatric Body Dysmorphic Disorder	Phase 4
Completed	`NCT02808702` - Brain Correlates of Self-Focused Processing	N/A
Completed	`NCT01002326` - Cognitive-Behavioral Therapy for Pediatric Body Dysmorphic Disorder	N/A
Active, not recruiting	`NCT01075672` - Outcomes of Cognitive Behavioral Therapy (CBT) Interventions Provided by Unlicensed Professionals	N/A
Completed	`NCT02671266` - Oxytocin Administration in BDD and OCD	Phase 2
Completed	`NCT01038128` - An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder	N/A
Completed	`NCT01398865` - Escitalopram Neuroimaging Supplement	N/A
Completed	`NCT00265109` - Effectiveness of Levetiracetam in the Treatment of Body Dysmorphic Disorder	Phase 4
Recruiting	`NCT04373629` - Perceptual Abnormalities and Their Malleability in BDD	N/A
Completed	`NCT01453439` - Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder	N/A
Completed	`NCT00106223` - Treatment Study Investigating New Cognitive Behavioral Therapy Treatment Manual for Body Dysmorphic Disorder	N/A
Active, not recruiting	`NCT00211809` - CBT as an Adjunct to SRIs in the Treatment of BDD	Phase 4